Supplementary Figure S2 from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

Lei Huang,Dongshu Chen,Derek Liu,Li Yin,Surender Kharbanda,Donald Kufe

DOI: https://doi.org/10.1158/0008-5472.22364769

2023-01-01

Abstract:Supplementary Figure S2 from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

What problem does this paper attempt to address?

Supplementary Figure S1 from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

Lei Huang,Dongshu Chen,Derek Liu,Li Yin,Surender Kharbanda,Donald Kufe

DOI: https://doi.org/10.1158/0008-5472.22364772.v1

2023-01-01

Abstract:Supplementary Figure S1 from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin
Supplementary Figure Legends from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

Lei Huang,Dongshu Chen,Derek Liu,Li Yin,Surender Kharbanda,Donald Kufe

DOI: https://doi.org/10.1158/0008-5472.22364775

2023-01-01

Abstract:Supplementary Figure Legends from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin
Data from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

Lei Huang,Dongshu Chen,Derek Liu,Li Yin,Surender Kharbanda,Donald Kufe

DOI: https://doi.org/10.1158/0008-5472.c.6494352.v1

2023-01-01

Abstract:AbstractDysregulation of β-catenin is of importance to the development of diverse human malignancies. The MUC1 oncoprotein is aberrantly overexpressed by most human carcinomas and associates with β-catenin. However, the functional significance of the MUC1-β-catenin interaction is not known. Here, we show that MUC1 increases β-catenin levels in the cytoplasm and nucleus of carcinoma cells. Previous studies have shown that glycogen synthase kinase 3β (GSK3β) phosphorylates β-catenin and thereby targets it for proteosomal degradation. Consistent with the up-regulation of β-catenin levels, our results show that MUC1 blocks GSK3β-mediated phosphorylation and degradation of β-catenin. To further define the interaction between MUC1 and β-catenin, we identified a serine-rich motif (SRM) in the MUC1 cytoplasmic domain that binds directly to β-catenin Armadillo repeats. Mutation of the SRM attenuated binding of MUC1 to β-catenin and MUC1-mediated inhibition of β-catenin degradation. Importantly, disruption of the MUC1-β-catenin interaction with the SRM mutant also attenuated MUC1-induced anchorage-dependent and -independent growth and delayed MUC1-mediated tumorigenicity. These findings indicate that MUC1 promotes transformation, at least in part, by blocking GSK3β-mediated phosphorylation and thereby degradation of β-catenin.
Supplementary Figure 1 from Protein Phosphatase-2A Is a Target of Epigallocatechin-3-Gallate and Modulates p53-Bak Apoptotic Pathway

Jichao Qin,He-Ge Chen,Qin Yan,Mi Deng,Jinping Liu,Stephan Doerge,Weiya Ma,Zigang Dong,David Wan-Cheng Li

DOI: https://doi.org/10.1158/0008-5472.22375460.v1

2023-01-01

Abstract:Supplementary Figure 1 from Protein Phosphatase-2A Is a Target of Epigallocatechin-3-Gallate and Modulates p53-Bak Apoptotic Pathway
Muc1 Oncoprotein Blocks Glycogen Synthase Kinase 3 Beta-Mediated Phosphorylation And Degradation Of Beta-Catenin

L. Huang

DOI: https://doi.org/10.1158/0008-5472.CAN-05-2474

IF: 11.2

2005-01-01

Cancer Research

Abstract:Dysregulation of beta-catenin is of importance to the development of diverse human malignancies. The MUC1 oncoprotein is aberrantly overexpressed by most human carcinomas and associates with beta-catenin. However, the functional significance of the MUC1-beta-catenin interaction is not known. Here, we show that MUC1 increases beta-catenin levels in the cytoplasm and nucleus of carcinoma cells. Previous studies have shown that glycogen synthase kinase 3 beta (GSK3 beta) phosphorylates beta-catenin and thereby targets it for proteosomal degradation. Consistent with the up-regulation of beta-catenin levels, our results show that MUC1 blocks GSK3 beta-mediated phosphorylation and degradation of beta-catenin. To further define the interaction between MUC1 and beta-catenin, we identified a serine-rich motif (SRM) in the MUCI cytoplasmic domain that binds directly to beta-catenin Armadillo repeats. Mutation of the SRM attenuated binding of MUCI to beta-catenin and MUC1-mediated inhibition of beta-catenin degradation. Importantly, disruption of the MUC1-beta-catenin interaction with the SRM mutant also attenuated MUC1-induced anchorage-dependent and -independent growth and delayed MUC1-mediated tumorigenicity. These findings indicate that MUCI promotes transformation, at least in part, by blocking GSK3 beta-mediated phosphorylation and thereby degradation of beta-catenin.
Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

Xiang-Ming Xu,Yong-Qing Zhou,Ming-Hai Wang

DOI: https://doi.org/10.1074/jbc.M414699200

IF: 5.485

2005-01-01

Journal of Biological Chemistry

Abstract:The beta-catenin pathway plays a critical role in the pathogenesis of certain types of cancers. To gain insight into mechanisms by which altered receptor tyrosine kinases regulate cytoplasmic beta-catenin accumulation, the effect of an oncogenic receptor originated from Nantes (RON) variant on beta-catenin accumulation and the role of beta-catenin in RON-mediated tumorigenic activities were studied. In NIH3T3 cells harboring oncogenic variant RON Delta 160, increased beta-catenin accumulation with tyrosine phosphorylation and nuclear translocation was observed. Overexpression of RON Delta 160 also resulted in increased expression of beta-catenin target genes c-myc and cyclin D1. By analyzing cellular proteins that regulate beta-catenin stabilities, it was found that RON Delta 160 activates the protein disheveled (DVL) and inactivates glycogen synthase kinase-3 beta by Ser-9 residue phosphorylation. These effects were channeled by RON Delta 160-activated PI 3-kinase-AKT pathways that are sensitive to specific inhibitors, such as wortmannin, but not to other chemical inhibitors. Silencing RON Delta 160 expression by specific small interfering RNA blocked not only beta-catenin expression but also c-myc and cyclin D1 expression, suggesting that RON expression is required for the activation of the beta-catenin signaling pathway. Moreover, it was found that knockdown of the beta-catenin gene expression by small interfering RNA techniques reduces significantly the RON Delta 160-mediated NIH3T3 cell proliferation, focus-forming activities and anchorage-independent growth. Thus, the oncogenic RON variant regulates beta-catenin stabilities through activation of DVL and inactivation of glycogen synthase kinase-3 beta. The activated beta-catenin cascade is one of the pathways involved in tumorigenic activities mediated by the oncogenic RON variant.
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Figure 6 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling

Ruyi Zhang,Shanshan Li,Kelly Schippers,Yunlong Li,Boaz Eimers,Marla Lavrijsen,Ling Wang,Guofei Cui,Xin Chen,Maikel P. Peppelenbosch,Joyce H.G. Lebbink,Ron Smits

DOI: https://doi.org/10.1158/0008-5472.25735976

2024-01-01

Abstract:response of β-catenin signaling in HEK293T cells following Wnt3A or GSK3β inhibitor addition
Supplementary Figure S4 from The CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment

Yanyan Qian,Jupeng Yuan,Huili Hu,Qifeng Yang,Jisheng Li,Shuqian Zhang,Baichun Jiang,Changshun Shao,Yaoqin Gong

DOI: https://doi.org/10.1158/0008-5472.22408071

2023-01-01

Abstract:Supplementary Figure S4. The expression level of β-catenin.
Supplementary Figure from Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function

Xixi Zhao,Yongkun Wei,Yu-Yi Chu,Yintao Li,Jung-Mao Hsu,Zhou Jiang,Chunxiao Liu,Jennifer L. Hsu,Wei-Chao Chang,Riyao Yang,Li-Chuan Chan,Jingkun Qu,Shuqun Zhang,Haoqiang Ying,Dihua Yu,Mien-Chie Hung

DOI: https://doi.org/10.1158/0008-5472.22431052.v1

2023-01-01

Abstract:Supplementary Figure from Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function
Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395239.v1

2023-01-01

Abstract:Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Figures 1-4 from Glioblastoma Proto-oncogene sec61γ is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress

Zhe‐Ming Lu,Lian Zhou,Patrick Killela,Ahmed Rasheed,Chunhui Di,William E. Poe,Roger E. McLendon,Darell D. Bigner,Christopher V. Nicchitta,Hai Yan

DOI: https://doi.org/10.1158/0008-5472.22383560.v1

2023-01-01

Abstract:Supplementary Figures 1-4 from Glioblastoma Proto-oncogene SEC61γ Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress
Supplementary Figure 2 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling

Ruyi Zhang,Shanshan Li,Kelly Schippers,Yunlong Li,Boaz Eimers,Marla Lavrijsen,Ling Wang,Guofei Cui,Xin Chen,Maikel P. Peppelenbosch,Joyce H.G. Lebbink,Ron Smits

DOI: https://doi.org/10.1158/0008-5472.25735988.v1

2024-01-01

Abstract:Analysis of the AXIN1 mutational landscape
Supplementary Figure 2 from Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma

Chen Liang,Yi Qin,Bo Zhang,Shunrong Ji,Si Shi,Wenyan Xu,Jiang Liu,Jinfeng Xiang,Dingkong Liang,Qiangsheng Hu,Quanxing Ni,Jin Xu,Xianjun Yu

DOI: https://doi.org/10.1158/1541-7786.22512181

2023-01-01

Abstract:ERK was involved in c-Myc expression in pancreatic cancer cells
Supplementary Figure from Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy

Mario R. Fernandez,Franz X. Schaub,Chunying Yang,Weimin Li,Seongseok Yun,Stephanie K. Schaub,Frank C. Dorsey,Min Liu,Meredith A. Steeves,Andrea Ballabio,Alexandar Tzankov,Zhihua Chen,John M. Koomen,Anders E. Berglund,John L. Cleveland

DOI: https://doi.org/10.1158/0008-5472.22431502

2023-01-01

Abstract:Supplementary Figure from Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy
Supplementary Figure S2 from the CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment

Yanyan Qian,Jupeng Yuan,Huili Hu,Qifeng Yang,Jisheng Li,Shuqian Zhang,Baichun Jiang,Changshun Shao,Yaoqin Gong

DOI: https://doi.org/10.1158/0008-5472.22408077

2023-01-01

Abstract:Supplementary Figure S2. Activation and immune effect of CD8+ T cells and NK cells.
Supplementary Figure 1 from Phosphorylation and Degradation of MdmX Is Inhibited by Wip1 Phosphatase in the DNA Damage Response

Xinna Zhang,Lin Lin,Huarong Guo,Jianhua Yang,Stephen N. Jones,Aart Jochemsen,Xiongbin Lu

DOI: https://doi.org/10.1158/0008-5472.22378946

2023-01-01

Abstract:Supplementary Figure 1 from Phosphorylation and Degradation of MdmX Is Inhibited by Wip1 Phosphatase in the DNA Damage Response
Supplementary Figure 4 from Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma

Chen Liang,Yi Qin,Bo Zhang,Shunrong Ji,Si Shi,Wenyan Xu,Jiang Liu,Jinfeng Xiang,Dingkong Liang,Qiangsheng Hu,Quanxing Ni,Jin Xu,Xianjun Yu

DOI: https://doi.org/10.1158/1541-7786.22512175.v1

2023-01-01

Abstract:FBW7 was involved in the expression and shedding of CA125
Supplementary Table3 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling

Ruyi Zhang,Shanshan Li,Kelly Schippers,Yunlong Li,Boaz Eimers,Marla Lavrijsen,Ling Wang,Guofei Cui,Xin Chen,Maikel P. Peppelenbosch,Joyce H.G. Lebbink,Ron Smits

DOI: https://doi.org/10.1158/0008-5472.25735949

2024-01-01

Abstract:Overview of the interactions at the interface between AXIN1 and GSK3β for the mutated amino acids and their predicted effects
Supplementary Figure 1 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling

Ruyi Zhang,Shanshan Li,Kelly Schippers,Yunlong Li,Boaz Eimers,Marla Lavrijsen,Ling Wang,Guofei Cui,Xin Chen,Maikel P. Peppelenbosch,Joyce H.G. Lebbink,Ron Smits

DOI: https://doi.org/10.1158/0008-5472.25736012

2024-01-01

Abstract:Immunofluorescence analysis of β-catenin following Wnt3A addition or transfection with various AXIN1 variants

Supplementary Figure S2 from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

Supplementary Figure S1 from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

Supplementary Figure Legends from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

Data from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

Supplementary Figure 1 from Protein Phosphatase-2A Is a Target of Epigallocatechin-3-Gallate and Modulates p53-Bak Apoptotic Pathway

Muc1 Oncoprotein Blocks Glycogen Synthase Kinase 3 Beta-Mediated Phosphorylation And Degradation Of Beta-Catenin

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure 6 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling

Supplementary Figure S4 from The CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment

Supplementary Figure from Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Figures 1-4 from Glioblastoma Proto-oncogene &lt;i&gt;sec61γ&lt;/i&gt; is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress

Supplementary Figure 2 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling

Supplementary Figure 2 from Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma

Supplementary Figure from Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy

Supplementary Figure S2 from the CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment

Supplementary Figure 1 from Phosphorylation and Degradation of MdmX Is Inhibited by Wip1 Phosphatase in the DNA Damage Response

Supplementary Figure 4 from Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma

Supplementary Table3 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling

Supplementary Figure 1 from Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling

Supplementary Figures 1-4 from Glioblastoma Proto-oncogene <i>sec61γ</i> is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress